These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7037354)

  • 41. [Combined antibacterial activity of clavulanic acid with amoxicillin and ampicillin against Gram-negative strains].
    Mascellino MT; Prignano G; Lorenzi A; Iegri F; Martorano E; Catania S; Ginanni Corradini S
    Boll Ist Sieroter Milan; 1984; 63(5):447-52. PubMed ID: 6335660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The antibacterial activity of amoxycillin/clavulanic acid against Staphylococcus aureus ingested by human granulocytes.
    Cuffini AM; Tullio V; Allocco A; Paizis G; Carlone NA
    Microbios; 1996; 87(350):31-8. PubMed ID: 8972100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Implications of beta-lactamase-inhibitor combinations.
    Fuchs PC; Barry AL
    J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bactericidal effects of amoxycillin/clavulanic acid against Legionella pneumophila.
    Stokes DH; Slocombe B; Sutherland R
    J Antimicrob Chemother; 1989 Jan; 23(1):43-51. PubMed ID: 2745255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amoxycillin with clavulanic acid and tetracycline in periodontal therapy.
    Abu Fanas SH; Drucker DB; Hull PS
    J Dent; 1991 Apr; 19(2):97-9. PubMed ID: 2050897
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural Variabilities in β-Lactamase (blaA) of Different Biovars of Yersinia enterocolitica: Implications for β-Lactam Antibiotic and β-Lactamase Inhibitor Susceptibilities.
    Singhal N; Srivastava A; Kumar M; Virdi JS
    PLoS One; 2014; 10(4):e0123564. PubMed ID: 25919756
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Augmentin treatment of bacterial infections in hospitalised patients.
    Ellis-Pegler RB; Lang SD; Downey DJ; Anderson MP
    N Z Med J; 1982 Aug; 95(713):542-5. PubMed ID: 6752781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biochemistry and action of clavulanic acid.
    Cole M
    Scott Med J; 1982; 27 Spec No.():S10-6. PubMed ID: 6762660
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
    Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of beta-lactamase inhibitors.
    Sutherland R
    J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative study of amoxycillin and amoxycillin/clavulanic acid in lower respiratory infections.
    Mehta AP; Phutane L; Patel MH; Rupwate RU; Kamat SR
    J Assoc Physicians India; 1991 Mar; 39(3):251-3. PubMed ID: 1880092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ciprofloxacin versus amoxycillin/clavulanic acid in the treatment of urinary tract infections in general practice.
    Abbas AM; Chandra V; Dongaonkar PP; Goel PK; Kacker P; Patel NA; Shrivastava OP; Thakkar B; Tillotson GS
    J Antimicrob Chemother; 1989 Aug; 24(2):235-9. PubMed ID: 2793646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
    Croom KF; Goa KL
    Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of clavulanic acid, given in combination with amoxycillin, in volunteers.
    Nilsson-Ehle I; Fellner H; Hedström SA; Nilsson-Ehle P; Sjövall J
    J Antimicrob Chemother; 1985 Oct; 16(4):491-8. PubMed ID: 4066561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative antibacterial properties in vitro of seven olivanic acid derivatives: MM 4550, MM 13902, MM 17880, MM 22380, MM 22381, MM 22382 and MM 22383.
    Basker MJ; Boon RJ; Hunter PA
    J Antibiot (Tokyo); 1980 Aug; 33(8):878-84. PubMed ID: 6968745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibacterial activity and synergy, in vitro and in vivo, of a combination of amoxycillin and flucloxacillin.
    Comber KR; Merrikin DJ; Sutherland R
    Chemotherapy; 1979; 25(1):30-9. PubMed ID: 253636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetic study of a paediatric formulation of amoxycillin and clavulanic acid in children.
    van Niekerk CH; van den Ende J; Hundt HK; Louw EA
    Eur J Clin Pharmacol; 1985; 29(2):235-9. PubMed ID: 3908124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase].
    Prát V; Horcicková M; Hatala M; Liska M; Matousovic K
    Cas Lek Cesk; 1985 Jun; 124(23):711-4. PubMed ID: 3874692
    [No Abstract]   [Full Text] [Related]  

  • 59. Antibiotic susceptibility of anaerobic bacteria isolated in Johannesburg.
    van der Westhuyzen I; Chalkley LJ
    S Afr Med J; 1992 Nov; 82(5):314-7. PubMed ID: 1448710
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Influence of amoxicillin combined with clavulanic acid on the fecal flora in children].
    Lambert-Zechovsky N; Bingen E; Proux MC; Aujard Y; Mathieu H
    Pathol Biol (Paris); 1984 May; 32(5):436-8. PubMed ID: 6739152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.